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Introduction
The thyroid hormones are known as one of the major factors that 
regulate cardiac metabolic and physiological functions1 Mitochondria 
is considered a subcellular target of thyroid hormone action and a 
major compartment of this hormone accumulation2,3. In recent years, 
nitric oxide (NO) signaling has been identified as an important trigger 
of cardioprotection in the mitochondria4. It is synthesized from 
L-arginine, NADPH and O2 in a reaction catalyzed by mitochondria 
NO synthase (mtNOS) isoform located in the mitochondrial inner 
membrane.5,6 The mtNOS is the α splice variant of neuronal nitric 
oxide synthetase isoform resulting in a novel Ca+2 dependent NOS 
subtyped.7,8 Thyroid hormones modulate NO steady-state level which 
may act as a messenger to modulate the mitochondrial bioenergetic 
function.9,10 In this context, NO modulates cellular respiration acting 
on the complexes of respiratory chain.11,12 It is well known that 
hypovolemia may lead sequentially to hemodynamic instability, 
decreased in oxygen delivery, tissue perfusion and cellular hypoxia.13 
The pathogenesis of organ injury secondary to this acute stress is still 
not completely understood. Experimental studies of our laboratory 
indicate that hypovolemic state induced by acute hemorrhage 
triggered a heterogeneous and dynamic NOS activation, modulating 
the cardiovascular response. Involvement of the NO pathway occurs 
in an isoform-specific and time-dependent manner.14 However, the 
exact mechanism underlying the effects of the thyroid hormones 
on heart mitochondrial NO production against acute hemorrhage is 
still unknown. Considering the mitochondria as an important target 
for thyroid hormone action and a crucial organelle associated with 
metabolic process related to cell survive in different pathological 
situations, we decided to examine rat heart mitochondrial function 
during thyroid disorder and hypovolemia. We also evaluate the role 
of NO as a probable messenger that underlines the actions of thyroid 
hormone at the mitochondrial level.
Materials and methods 
Animals 
Male Sprague-Dawley rats of 2 months old from the breeding 
laboratories of the School of Pharmacy and Biochemistry (Universidad 
de Buenos Aires, Argentina) were used throughout the study. Rats 
were housed in humidity- and temperature-controlled environment 
with an automatic 12h light: 12h darkness cycle. All procedures were 
reviewed and approved by the National Food, Drug and Medical 
Technology Administration (ANMAT), National Department of 
Health and Environment, Argentina (No. 6344/96) and CICUAL N° 
0054570. Rats were randomly assigned to one of the three groups:
 Control rats (Eut, n=16), animals who received i.p injections of 
0.9% NaCl (0.1 ml/100g body weight) every 2nd day for 28 days. 
T3-treated rats (Hyper, n=16), animals received i.p injections of 
triiodothyronine (T3) (Sigma, 20 ug/100g body weight) every 2
nd day 
for 28 days.15
Methimazole-treated rats (hypo, n=16), animals were rendered 
hypothyroid after 28 days of treatment with 0.02% methimazole (w/v) 
in the drinking water.16 
Determination of treatment efficacy
Serum thyroid-stimulating hormone (TSH), total T3 and thyroxin 
(T4) (TSH kit, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health, Bethesda, USA) were 
measured by radioimmunoassay at the beginning and the end of the 
experimental period.17
Hemodynamic parameters 
After 28 days of treatment, the animals were anesthetized with 
urethane (1 g/kg ip). A tracheotomy was performed using polyethylene 
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Abstract
The aim of the present work was to examine the effect of thyroid state on rat heart 
mitochondria function during hypovolemia. Sprague-Dawley rats treated with T3 
(hyper, 20 μg/100 g body weight) or 0.02% methimazole (hypo, w/v) for 28 days. 
Hypovolemia was induced by acute hemorrhage. O2 uptake, complex I activity and 
mitochondrial nitric oxide synthase (mtNOS) protein levels were determined in heart 
mitochondria. The malate-glutamate-supported state 3 respiration decreased and 
increased in hypo and hyperthyroid rats, while state 4 respirations did not change. 
Complex I activity and mtNOS protein levels were decreased in hypothyroid rats even 
in acute hypovolemia. Hyperthyroidism did not change these parameters. In summary, 
this study showed, for the first time, interesting findings that heart mitochondrial 
function is altered during thyroid disorder and acute hypovolemia. Heart mitochondrial 
nitric oxide, modulating oxygen uptake, may be involved in the adaptative response to 
assure the cardiomyocytes survives in this experimental condition.
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tubing (4mm ID, Portex). Mean arterial pressure (MAP) was measured 
through a cannula inserted into the right femoral artery and connected 
to a pressure transducer (Statham P23 ID, Gould Inst, Cleveland, OH, 
USA). Measurements were recorded with a polygraph (Physiograph 
E & M, Houston, TX, USA) during the whole experiment. Heart 
rate (HR) was determined from the pulsatile pressure signal by 
beat-to-beat conversion with a tachograph amplifier (model S77-
26 tachometer, Coulbourn Instruments, Allentown, PA, USA). The 
Labtech Notebook program (Laboratory Technology, Wilmington, 
MD, USA) was used for data acquisition.
Experimental protocol
Eut, Hyper and hypo animals were subdivided into two 
experimental groups:
1) Control rats (C). After a 30-min stabilization period, MAP and 
HR were continuously recorded over a 120-min period. (n=8 each 
group).
2) Hemorrhaged rats (H). After a 30-min stabilization period, 
basal MAP and HR were measured over a 5-min period. Subsequently, 
the acute hemorrhage was performed. Thereafter, hemodynamic 
parameters were continuously recorded over a 120-min period after 
the bleeding (n=8 each group). The hypovolemic state in H was 
induced through an acute hemorrhage using a cannula inserted in the 
left femoral artery (Riviero, PR10). The bleeding was done by a loss 
of 20% of the blood volume for 2 min. The volume of blood loss was 
calculated individually for every animal, from the total blood volume 
(7% of the body mass).
Heart mitochondrial isolation 
Heart mitochondria were obtained from tissue homogenates by 
differential centrifugation (Sorvall- Instruments-Du Pont, Model 
RC5S, Buckinghamshire, England) in an ice-cold medium (1/10) 
containing 230 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM 
Tris–HCl, pH 7.4 (MSTE) for 15 s with a blade homogenizer (Kendro-
Sorvall-Du Pont Inst., Asheville, NC, USA) and by five strokes in 
a glass–Teflon homogenizer. The homogenates were centrifuged at 
600g for 10 min to discard nuclei and cell debris and the supernatant 
was centrifuged at 8000g for 10 min to precipitate mitochondria, 
which were washed with MSTE. All procedure was carried out at 0–4 
°C. Protein concentrations were determined with the Folin reagent, 
using bovine serum albumin (BSA) as standard.18
Mitochondrial O2 consumption
 Mitochondrial O2 uptake was measured polarographically with 
a Clark-type electrode (Hansatech Oxygraph, Hansatech Instruments 
Ltd, Norfolk, England). State 4 respiration was determined at 30 °C in 
an air-saturated (220 μM O2) reaction medium consisting of 120 mM 
KCl, 5 mM KH2PO4, 1 mM EGTA, 3 mM HEPES, 1 mg ml
−1 BSA, 2 
mM malate and 5 mM glutamate (complex I substrates), pH 7.20, and 
heart mitochondrial suspension (0.1–0.3 mg mitochondrial protein 
ml−1). State 3O2 consumption rate was established by supplementation 
of this medium with 0.5 mM ADP19. Respiration was expressed in 
ng-at O/min. mg protein, and respiratory control was calculated as the 
ratio of state 3/state 4 respiration rates. 
Complex I activity 
The enzyme activity of complex I was determined 
spectrophotometrically (Beckman DU 7400 spectrophotometers; 550 
nm, ε=19mM−1 cm−1) as NADH-cytochrome c reductase at 30 °C with 
mitochondrial membranes suspended in 100 mM KH2PO4/K2HPO4, 
pH 7.4. Mitochondrial membranes were added with 0.2mM NADH, 
25μM cytochrome c3+, and 0.5 mM KCN. Enzymatic activities were 
expressed as nmol reduced cytochrome c/min. mg protein.20 
Western blot analysis 
The proteins of mitochondrial membranes (0.10 mg protein/lane) 
were separated by electrophoresis in 7.5% SDS-polyacrylamide gels 
and transferred to a nitrocellulose membrane (Bio-Rad, Munich, 
Germany) and then incubated with rabbit polyclonal anti-neuronal 
NOS (BD Transduction Laboratories, USA) and anti-VDAC-1/2/3 
(FL-283: sc-98708, Santa Cruz Biotechnology, CA) antibodies [1:500 
dilution] and a horseradish peroxidase-conjugated goat anti-rabbit 
secondary antibody (1:5,000 dilution). Samples were revealed by 
chemiluminescence using the enhanced chemiluminescence reagent 
(Amersham Pharmacia Biotechnology, Uppsala, Sweden) for 4 min. 
Quantification of the bands was performed by digital image analysis 
using a Hewlett-Packard scanner and Totallab analyzer software 
(Biodynamics, Seattle, WA). Data were expressed as relative to 
VDAC-1/2/3 expression (loading control). All experiments were 
performed in triplicate.15
Statistical analysis 
Data in tables and figures are mean values ±SEM. Data were 
evaluated with univariate and multivariate approaches for a completely 
randomized design, with a structure of two factors (hemorrhage and 
thyroid hormones). For each variable, ANOVA or MANOVA analysis 
was performed when appropriate. The Levene’s and Shapiro-Wilk’s 
tests were used to evaluate homogeneity of variances and normality 
of data, respectively. When normality and homogeneity of variances 
assumptions were satisfied, the Bonferroni multiple comparison 
test was run. In the case of non-homogenous variances, a multiple 
comparison test, such as Tamhane, was run. To detect association 
among variables, a correlation analysis was performed and the 
Pearson coefficient was calculated. All statistical procedures were 
performed using the SPSS statistical software package version 22.0 
statistical significance was set at P<0.05.
Results
Treatment efficacy 
TSH plasmatic levels were higher and lower in hypo and Hyper 
rats respectively. T3 and T4 levels decreased in hypo rats, while T4 
increased in Hyper animals. Body weights and basal MAP values 
were similar in the three groups of animals. However, basal HR values 
were lower and higher in hypo and Hyper rats compared with Eut 
animals, respectively. Bleeding induced a decreased of MAP values 
in all experimental groups. However, animals with thyroid disorder 
exhibited a lower MAP values at 120 minutes of hemorrhage than Eut 
rats (Table 1). 
Mitochondrial respiratory function
The malate-glutamate-supported state 3 respiration was decreased 
in hypo rats and increased in hyper rats. Hemorrhage did not 
change state 3 respiration in all groups of animals. No differences 
were observed in malate-glutamate-supported state 4 between 
experimental groups. Withdrawal did not modify this state (Table 2). 
Respiratory control and ADP-to-O ratios were high indicating that 
the mitochondria were well coupled and able to effectively carry out 
oxidative phosphorylation. After bleeding, it was observed a tendency 
of ADP-to-O ratio to decrease in hypo animals (Table 2). 
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Table 1 Biological variables
Animals Eut Hypo Hyper 
TSH (ng/ml) 14.75±0.83 35.57±4.35* 5.57±0.03*
T3 (ng/dl) 1.131±0.123 0.750±0.036* 1.034±0.036
T4 (ug/ml) 2.475±0.031 1.034±0.036* 3.775±0.270*
BW (g) 337±12 338±12 298±12
Basal HR (bpm) 352±15 214±13* 424±15*
At 120 min HR (bpm) 364±12 222±10* 480±10*
Basal MAP(mmHg) 80±4 70±4 76±2
At 120 min MAP (mmHg) 58±3 45±2* 41±2*
LVIDd (mm) 5.40±0.18 5.99±0.19* 4.7±0.10*
LVIDs (mm) 2.80±0.06 3.01±0.10* 2.21±0.07*
EF (%) 86±3 83±1* 88±3
FS (%) 56±2 46±2* 51±2
Eut, Euthyroid rats; hypo, Hypothyroid rats; Hyper, Hyperthyroid rats; TSH, Thyroid-stimulating hormone; T3 Triiodothyronine; T4, Total thyroxine; BW, Body 
weight; HR, Heart rate; MAP, Mean arterial pressure; LVIDd LV internal diameter in diastole; LVIDs, LV internal diameter in systole; EF, Ejection fraction; FS, 
Fractional shortening. Data are mean ± SEM; n=15;*P<0.05 vs Eut rats.
Table 2 Heart mitochondria function in thyroid disorder and hypovolemia
O2 Uptake, ng-atoms O min -1mg protein-1  
Malate-glutamate
State 4 State 3 Respiratory control ratio ADP-to-O ratio
Eut 42 ± 3 216 ± 13 5.2 2.50 ± 0.08
EutH 45 ± 3 228 ± 10 5.1 2.49 ± 0.17
hypo 35 ± 2 177 ± 7* 5.1 2.54 ± 0.19
hypoH 40 ± 2 174 ± 4 4.3 2.13 ± 0.06
Hyper 40 ± 2 260 ± 14* 6.5 2.54 ± 0.09
HyperH 42 ± 2 257 ± 13 6.1 2.57 ± 0.23
Eut, Euthyroid rats; hypo, Hypothyroid rats; Hyper, Hyperthyroid rats; H, Hemorrhaged. Data are mean ± SEM; n=15; *P<0.05 vs Eut rats.
Complex I activity 
Enzyme activity was only decreased in hypo rats. This activity was 
increased after bleeding in hypo animals. The complex I activity did 
not change in Hyper animals and the bleeding did not change this 
parameter (Table 3). 
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 Table 3 Complex I activity in heart mitochondria in thyroid disorder and 
hypovolemia
Animals Complex I (nmol/min .mg protein)
Eut 204 ± 44
Eut H 182 ± 18
hypo 117 ± 16*
hypo H 147 ± 17†
Hyper 179 ± 14
Hyper H 179 ± 10
Eut, Euthyroid rats; hypo, Hypothyroid rats; Hyper, Hyperthyroid rats; H, 
Hemorrhaged. Data are mean ± SEM; n=15; *P<0.05 vs Eut rats; † P<0.05 vs 
rats without hemorrhage.
Nitric oxide synthase in heart mitochondria 
Figure 1 showed that hypothyroidism decreased nNOS protein 
levels compared with Eut group. This protein levels did not change 
in Hyper animals. Withdrawal decreased nNOS protein levels in hypo 
and Eut rats, while did not change in Hyper animals.
Figure 1 Representative Western Blots of nNOS levels, carried 
out on proteins from euthyroid (Eut), hypothyroid (hypo) and 
Hyperthyroid (Hyper) in heart mitochondria. The values are mean 
± SEM; n=15/group; *P<0.05 vs Eut rats; † P<0.05 vs rats without 
hemorrhage. Histograms illustrate the mean NOS protein values for 
each group. All experiments were performed in triplicate. Each blot 
was normalized with the expression of the VDAC from the same gels. 
Data are mean ± SEM; n=7/group; *P<0.05 vs Eut ats; † P<0.05 vs 
rats without hemorrhage. EutH: euthyroid hemorrhaged rats; hypoH: 
hypothyroid hemorrhaged rats; HyperH: hyperthyroid hemorrhaged 
rats.
Discussion 
This study showed, for the first time, interesting findings that 
heart mitochondrial function is altered during thyroid disorder and 
acute hypovolemia. Heart mitochondrial NO, modulating oxygen 
uptake, may be involved in the adaptative response to assure the 
cardiomyocytes survives in this experimental condition.
Several authors show that thyroid hormones have a special role 
regulating heart function. In this context, cardiovascular system 
regulation would be crucial in these pathological situations of 
hypovolemia. In this study, TSH measurements showed that both 
treatments were effective to establish thyroid disorder. Basal MAP 
values were similar in all experimental groups of rats. These findings 
were like those obtained by us previously and were discussed 
previously.21 The hemodynamics changes let us to evaluate the 
mitochondrial function in the experimental groups. The determination 
of this function was achieved by measuring O2 consumption in presence 
of saturating concentrations of the respective substrates.22 Thyroid 
state only affects state 3 of respiration using malate-glutamate as a 
substrate, while no changes were observed in oxygen consumption 
during state 4. Additionally, it is important to note that oxygen uptakes 
did not change in hypovolemic induced-acute cellular stress. Complex 
I activity decreased only in hypothyroidism. This finding agreed with 
those found by several authors.16–23 This effect could be probably 
controlled by a variety of mechanisms such as reduced content and 
activity of some components of the electron transport chain, alterations 
of mitochondrial membranes permeability as well as changes in 
lipid composition.23,24 Additionally, Mukherjee et al.,25 showed that 
complex I activity was inhibited in hypothyroid submitochondrial 
particles, whereas T3 supplementation upregulated electron transport 
chain complexes. Although it is well known that T3 upregulates all 
the respiratory chain complexes of inner mitochondrial membrane 
accounting for enhanced oxygen consumption as it was shown by our 
results. On the other hand, we observed that hemorrhage decreased 
this complex I activity only in hypo group. In accordance with our 
results, we suggest that complex I seems to be a vulnerable target in 
hypothyroid condition. While several factors may be responsible of 
this effect, we focused on mitochondrial NO production. The results 
showed that mtNOS protein levels only decreased in hypo animals 
compared with Eut rats. This result would be disagreed with several 
authors who showed in other tissues like liver and skeletal muscle, 
an increased mtNOS expression in hypothyroidism.16–26 That is, 
hypothyroidism is associated with a lower activity of complex I and 
lower mtNOS protein level in mitochondrial heart compared with 
Eut animals. Parihar et al. showed a similar result suggesting that rat 
liver and brain mtNOS are functionally associated with mitochondrial 
respiration chain complex I.27 Additionally, our study also showed 
that this interaction would depend on thyroid hormone levels. 
Interestingly, mitochondrial dysfunction is often associated with 
critical care diseases such as sepsis, trauma and acute hemorrhagic.28 
The results show that in our experimental conditions the hypovolemia 
induced by acute bleeding did not modify the oxygen consumption 
in any of the three groups of animals. On the other hand, we also 
show that the maintenance of normal respiration after bleeding was 
associated with a decrease in the levels of mtNOS only in Eut and 
hypothyroid animals. These findings suggest that mtNOS would be 
related to energy demand and it reacts differently depending thyroid 
state and volemia. 
Conclusion
The data presented in this study provide the following novel 
information: heart mitochondrial function is altered during thyroid 
disorder and acute hypovolemia. The decrease of thyroid hormone 
level would probably be a hormonal environment that promotes 
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changes in mitochondrial NO bioavailability modulating oxygen 
consumption and cell respiration even against acute hypovolemic 
stress. Alterations of complex I activity could mediate these effects.
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